What you can do if you have 'mild' COVID-19 symptoms, according to new AIIMS/ICMR guidelines
Centers for Disease Control and Prevention
- The All India Institute of Medical Sciences (
AIIMS) and Indian Council of Medical Research ( ICMR) have combinedly issued new guidelines for treatment of mild, moderate and severe cases of COVID-19.
- In case of mild COVID-19, AIIMS guidelines recommend home isolation and care.
- For full details, check out the list below.
With COVID-19 cases exploding across India and hospitals facing acute shortage of oxygen and other critical requirements, it’s important for you to keep a track of your health, and identify
Treatment of mild COVID-19 cases
AdvertisementIn case you have a mild case of COVID-19, you can avoid the trip to the hospital and take care of yourself at home. Here’s what the new AIIMS guidelines suggest:
How to identify
A patient is said to have mild COVID-19 in case they have upper respiratory tract symptoms and/or fever without shortness of breath or hypoxia.
Hypoxia means there is a shortage of adequate supply of oxygen at the tissue level. It can be identified by checking SpO2 levels using an oximeter.
SpO2 levels should be between 92% to 98%, anything lower than 92% is considered as hypoxia.
AIIMS guidelines suggest home isolation and care.
- Physical distancing, indoor mask use and strict hand hygiene.
- Symptomatic management (hydration, antipyretics, antitussive, multivitamins).
- Stay in contact with the treating physician.
- Monitor temperature and oxygen saturation (by applying a SpO2 probe to fingers).
- Difficulty in breathing.
- High grade fever/severe cough, particularly if it lasts for more than five days.
- A low threshold to be kept for those with any of the high-risk features.
Note that these therapies are based on low certainty of evidence.
- Tab Ivermectin (200 mcg/kg once a day for 3 days). Avoid in case of pregnant and lactating women.
- Tab HCQ (400 mg twice for 1 day, followed by 400 mg once daily for 4 days) unless contraindicated.
If the COVID-19 vaccine prices are too high for some, then why not use direct benefit transfer
The COVID-19 crisis in India is getting worse with state administrations trying to hoard oxygen
There is a virtual lockdown in the world’s fourth largest automobile market
- Bharat Biotech begins covid 19 COVAXIN supply to 14 states based on central government's guidance
- This is the time for brands to play their part as responsible corporate citizens: Dheeraj Sinha, Leo Burnett
- Fauci, America's top medical advisor, calls on countries to help India make vaccines
- Karnataka witnesses chaos on the first day of its two-week lockdown
- KR Gowri, political leader and member of Kerala's first ministry, passes away